Surrey Heartlands

Joint Formulary & PAD

Vonicog alfa - von Willebrand deficiency

You are here : Home > Formulary Search > Vonicog alfa - von Willebrand deficiency

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NHSE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Vonicog alfa
Indication :
von Willebrand deficiency
Group Name :
Keywords :
haemophilia, bleeding disorders
Brand Names Include :
Veyvondi
Important Information :
NHS England - specialist centres only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Vonicog alfa is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat von Willebrand deficiency.

  • No records returned.

Committee Recommendations (1)

04 Nov 19 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.